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Background. Oral submucous ﬁbrosis is a chronic, insidious oral mucosal condition aﬀecting the most parts of the oral cavity with
high malignant transformation rate triggered by areca nut chewing, nutritional deﬁciencies, immunologic processes, and genetic
predisposition. OSF causes signiﬁcant hematological abnormalities resulting in anemia and a decrease in serum iron levels. Aim.
The aim of this study was to estimate the hemoglobin and serum iron levels among patients with oral submucous ﬁbrosis and
to compare the values with healthy subjects. Materials and Methods. In this hospital-based study 30 diagnosed patients of OSMF
and 15 healthy individuals were included, and the values of hemoglobin and serum iron levels were estimated using Sahli’s and
Ferrenemethods.Results.OSMFpatientsshowedsigniﬁcantlylowerlevelsofhemoglobinandserumironwhencomparedwiththe
healthy subjects. Conclusion. The ﬁndings of the study emphasizes on the assessment of hemoglobin and serum iron for patients
with oral submucous ﬁbrosis. Also iron therapy should be instituted concomitantly with the initial diagnosis which helps to cease
the further progression of the condition. Further extensive studies are indicated to understand the correlation between OSMF and
iron deﬁciency.
1.Introduction
Oral submucous ﬁbrosis (OSMF), ﬁrst described in the
early 1950s, is a potentially malignant disease predominantly
seen in people of Asian descent. It is a chronic progressive
disorder, and its clinical presentation depends on the stage
of the disease at detection. The majority of patients present
with an intolerance to spicy food and rigidity of lip, tongue,
andpalateleadingtovaryingdegreesoflimitationofopening
of the mouth and tongue movement. The hallmark of the
disease is submucosal ﬁbrosis that aﬀects most parts of the
oral cavity, pharynx, and upper third of the esophagus.
The disease is predominantly seen in India, Bangladesh,
Sri Lanka, Pakistan, Taiwan, Southern China, Polynesia,
and Micronesia. Several case series are reported among
Asian immigrants to the UK and South and East Africa. A
signiﬁcant variation in the prevalence of OSF in diﬀerent
countries has been reported [1].
Etiological factors hypothesized to trigger the disease
process include areca nut chewing, nutritional deﬁciencies,
immunologic processes, and genetic predisposition [2, 3].
Nutritional deﬁciencies, primarily of iron and vitamins, are
implicated in the etiology of OSMF. Iron is essential for the
overall integrity and health of epithelia of digestive tract and
its contribution to normal enzymatic functions. OSMF is
also considered as an Asian version of sideropenic dysphagia,
wherein chronic iron deﬁciency leads to mucosal susceptibil-
ity to irritants, such as chilies and areca nut products [4].
Hemoglobin levels, in particular serum iron levels, are
considered as biochemical indicators for nutritional assess-
ment [5]. Deﬁciency of iron, Vitamin B-12, and folate can
aﬀecttheintegrityoftheoralmucosa.Signiﬁcanthematolog-
ical abnormalities have been reported in OSMF, including an
increased blood sedimentation rate, and a decrease in serum
iron and an increase in total iron binding capacity [6].2 The Scientiﬁc World Journal
Thus, the present study is conducted to assess the level
of hemoglobin and serum iron binding capacity among
clinically and histopathologically diagnosed patients with
oral submucous ﬁbrosis and comparing the values with that
of healthy subjects.
2.MaterialandMethods
A hospital-based clinical study was conducted from Decem-
ber 2008 to December 2010 in 30 clinically diagnosed and
histopathologically proven patients of OSMF (OSMF group)
attending the Department of Oral Medicine and Radiology,
People’s College of Dental Sciences and Research Center,
Bhopal, India. This is a case control study where cases were
selected based on the simple randomized sampling method.
Patients with habit of chewing areca nut or one of its com-
mercialpreparations,withthepresenceofburningsensation,
inability to consume spices, stiﬀness of buccal mucosa,
vesicle formation, ulceration, and blanching of oral mucosa
wereincludedintheOSMFgroup.Patientswithanysystemic
complications, suﬀering from any major illness, and habit of
chewing only tobacco and patients with habit chewing areca
nutoroneofitscommercialpreparationsbutwithoutOSMF
were excluded. The OSMF group was clinically staged into
stage I and stage II as per the staging given by Pindborg [7].
Fifteen healthy individuals, matched for gender and age,
without any history of habit of chewing areca and tobacco
andanymajorillnessinrecentpastwereincludedascontrols.
Subjects with any habits and suﬀering from any systemic dis-
ease in the recent past were excluded from the control group.
Institutional ethical clearance and informed consent was
obtained from the individuals who participated in the study.
Five mL of fasting venous blood was collected and sub-
mitted for the estimation of hemoglobin levels by using
Sahli’s method [8] and serum sample for serum levels of iron
by using Ferrene method [9].
3.StatisticalAnalysis
The values obtained were statistically analyzed using Stu-
dent’s t-test to ﬁnd the signiﬁcance of study parameters on
a continuous scale for intergroup analysis. Pearson’s Cor-
relation test was performed to test the homogeneity of sam-
ples based on the parameters and categorical scale between
two groups. Analysis of variance (ANOVA) has been used to
ﬁnd the signiﬁcance of the study. SPSS software version 11
was used for statistical analysis.
4. Results
The study group (OSMF group) comprised of 30 cases with
age between 17 and 44 years with a mean age of 28.7 years.
The maximum numbers of cases were between 21 and 25
years. The OSMF group showed male predominance with 29
males and 1 female (Figures 1 and 2).
Mean values of hemoglobin and serum iron levels of
Control group were 15mg/dL and 140.13mcg/dL, whereas
those of OSMF group were 10.85mg/dL and 55.53mcg/dL
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Figure 1: Gender distribution in study groups.
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Figure 2: Age distribution in OSMF group in years.
respectively. On comparison of OSMF group with the Con-
trol group, OSMF group showed signiﬁcantly lower levels of
hemoglobin and serum iron with P<0.0001 (Figures 3 and
4).
Mean values of hemoglobin levels of Control group
were 15mg/dL and serum iron levels were 140.13mcg/dL.
Mean values of hemoglobin levels of OSMF stage II group
were 9.97mg/dL and serum iron levels were 49.73mcg/dL
respectively. Interstage comparison of OSMF stage II group
with the Control group, and OSMF stage II group showed
signiﬁcantly lower levels of hemoglobin and serum iron with
P<0.0001 (Figures 5 and 6).
On analyzing the values by Pearson’s correlations, it was
observed that values of hemoglobin level had signiﬁcant
correlation with serum iron levels in the OSMF stage II
(correlation value: −0.0754) (Figure 7).
5. Discussion
Oral submucous ﬁbrosis (OSMF) is a chronic, insidious
oral mucosal condition that occurs predominantly amongThe Scientiﬁc World Journal 3
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Figure 4: Mean serum iron levels in OSMF and control groups.
Indians and occasionally in other Asians. In the Indian
continent alone, the statistics for OSMF is about 5 million
people (0.5%) of the population [10]. The reasons for the
rapid increase of the disease are reported to be due to an
upsurge in the popularity of commercially prepared areca
nut preparations (pan masala) in India and an increased
uptake of this habit by young people due to easy access,
eﬀective price changes, and marketing strategies [11].
The hallmark of the disease is submucosal ﬁbrosis that
aﬀects the oral cavity and progressively involves the pharynx
and the upper esophagus. This leads to burning sensation in
the oral cavity, blanching, and stiﬀening of oral mucosa and
oropharynx, resulting in restricted mouth opening which
in turn causes limited food consumption, and diﬃculty in
maintaining oral health and impairs the ability to speak
[12, 13] .T h em e a na g eo ft h eO S M Fg r o u pi no u rs t u d yw a s
26.85 years, which is consistent with ﬁndings of 29.04 years
by Katharia et al. [14] and 30 years by Maher et al. [15].
Soluble irritants, such as capsaicin in chilies and spices,
were observed as one of the predisposing factors of OSMF
and alkaloids of areca nut act as initiating factors causing
a juxta-epithelial inﬂammatory reaction [16]. One of the
mechanisms that can lead to increased ﬁbrosis is by reduced
degradation of collagen by forming a more stable collagen
structure. The large quantities of tannin present in areca
nut reduce collagen degradation by inhibiting collagenases
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Figure 6: Mean serum iron level in OSMF stage I, OSMF stage II
and control groups.
and result in ﬁbrosis, as the combined eﬀect of tannin and
arecoline by reducing degradation and increased production
of collagen, respectively [17].
A male predominance was seen in the OSMF group with
1 female and 29 males. Our ﬁndings of male predominance
are consistent with Ranganathan et al. [11]. Males were
found to be dominating, as they were using gutkha and
other related products more because of easy availability in all
the places whereas females were more conscious about their
health and esthetic value and probably felt uncomfortable
to ask the vendors in getting the gutkha products. This may
be one of the reasons, which may be responsible for a high-
male-to female ratio.
Burning sensation, vesiculation, and ulceration of the
oral mucosa render a phase for diﬃculty in consumption
of the normal diet leading to poor nutrition. Deﬁciency
of iron and vitamin B complex other trace elements due
to nutritional depletion could possibly initiate anemia and
altered cell-mediated immunity, which in turn acts as a
promoting factor to this preexisting pathologic response of
the lamina propria [16]. After a frank establishment of the
lesion, anemia may further perpetuate by inadequate intake
of food due to ﬁbrosis and trismus [4].
Low levels of hemoglobin and serum iron are suggestive
of iron deﬁciency anemia [18]. Iron deﬁciency anemia in
patients with OSMF could be related to the precancerous4 The Scientiﬁc World Journal
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Figure 7: Pearson’s correlation coeﬃcient graph of hemoglobin
(%) levels and serum iron levels in OSMF stage II showing a
signiﬁcant correlation (correlation value: −0.0754).
nature of this condition. In the present study, OSMF group
shows signiﬁcant lower levels of hemoglobin and serum iron
on comparison with the values of the control group. Studies
with similar results are reported by Anuradha and Devi [19]
and Khanna and Karjodkar [20].
Cytochrome oxidase is an iron-dependent enzyme which
is required for the normal maturation of the epithelium.
In iron deﬁciency state, the levels of cytochrome oxidase
are low, consequently leading to epithelial atrophy. An
atrophic epithelium makes the oral mucosa vulnerable to the
soluble irritants [21]. Fibrosis dictates that OSMF is basically
a disorder of collagen metabolism. Hydroxyproline is an
amino acid found only in collagen, which is incorporated in
the hydroxylated form. This hydroxylation reaction requires
ferrous iron and ascorbic acid. Utilization of iron, for the
hydroxylation of proline and lysine, leads to decreased serum
iron level [20]. In OSMF patients, there is an increase in the
production of highly cross-linked insoluble collagen type I
loss of more soluble procollagen type III and collagen type
VI. The cross-linking of collagen due to the upregulation
of lysyl oxidase, plays a crucial role in the development and
progression of the condition [22].
From the aforementioned discussion, it is evident that a
suggestively signiﬁcant lower level of hemoglobin and serum
iron can be accepted in stage II OSMF patients than in stage
I, concluding that serum iron levels also deplete as disease
progresses. Serum iron content can be a predictor for the
progression of the condition. There appears an association
between serum iron content and oral carcinogenesis.
It is documented that patients with severe iron deﬁciency
condition, known as sideropenic dysphagia, are at a higher
risk of developing oral carcinoma, postcricoid carcinoma
and esophageal carcinoma. Though OSMF is a clinically
benign condition, it is a potentially malignant disease.
Malignant transformation rate of OSMF has been reported
to be around 7.6% over a 17-year period [10].
Although OSMF and iron deﬁciency anemia exist as
separate conditions, the clinical ﬁndings of OSMF mimic
those of iron deﬁciency anemia, which includes blanching,
burning sensation, and dysphagia. Due to a qualitative and
quantitative defect in the oxygen and nutrient perfusion of
the lamina propria and the overlying mucous membrane
histologically, epithelial atrophy occurs. The eﬀect of soluble
irritants on the atrophic epithelium, which ensues in due
course, leads to malignancy. Thus, this unclear line of
demarcation still persists, which calls upon for further
extensive studies to understand the correlation between
OSMF and iron deﬁciency as well as the validation of serum
iron levels in various stages of OSMF, as an indicator of
malignant transformation.
6. Conclusions
The present study emphasizes on the serum iron assessment
for patients with oral submucous ﬁbrosis. Determining iron
status is a part of biochemical assessment, which may be of
proactive intervention for high-risk groups. It is suggested
that the biochemical assessment of oral precancerous condi-
tions mayhelp in earlydiagnosis and prognosis. Italso serves
in predicting the malignant potential, especially in high-risk
groups.
It is also of key importance that iron therapy should
be instituted parallel with the initial diagnosis along with a
proper balanced diet, as a part of the overall treatment of
oral submucous ﬁbrosis with other modes of treatment. This
helps to stop the further progression of the condition.
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